title: At the frontiers of lung fibrosis therapy.
mesh_terms: D000594:Amino Acid Oxidoreductases; D000911:Antibodies, Monoclonal; D017209:Apoptosis; D035843:Biomedical Research; D016503:Drug Delivery Systems; D006801:Humans; D011658:Pulmonary Fibrosis / Q000188:drug therapy / Q000503:physiopathology; D016212:Transforming Growth Factor beta
chemical_list: D000911:Antibodies, Monoclonal; D016212:Transforming Growth Factor beta; D000594:Amino Acid Oxidoreductases; C119091:LOXL2 protein, human
references.citation: Nat Med. 2010 Sep;16(9):1009-17
references.pmid: 20818376
references.citation: N Engl J Med. 2011 Sep 22;365(12):1079-87
references.pmid: 21992121
references.citation: Lancet. 2011 May 21;377(9779):1760-9
references.pmid: 21571362
references.citation: Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
references.pmid: 21471066
references.citation: Nat Med. 2008 Jan;14(1):45-54
references.pmid: 18066075
references.citation: N Engl J Med. 2012 May 24;366(21):1968-77
references.pmid: 22607134
references.citation: Eur Respir Rev. 2013 Jun 1;22(128):148-52
references.pmid: 23728868